Lymphoid Interstitial Pneumonia and Other Benign Lymphoid Disorders

Antonella Arcadu; Teng Moua; Eunhee S. Yi; Jay H. Ryu

doi:10.1055/s-0036-1580691

Seminars in Respiratory and Critical Care Medicine, Table of Contents

Semin Respir Crit Care Med 2016; 37(03): 406-420
DOI: 10.1055/s-0036-1580691

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Lymphoid Interstitial Pneumonia and Other Benign Lymphoid Disorders

Authors

Antonella Arcadu

¹Department of Respiratory Disease, University of Sassari, Sassari, Italy
Teng Moua

²Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota
Eunhee S. Yi

³Division of Anatomic Pathology, Mayo Clinic, Rochester, Minnesota
Jay H. Ryu

²Division of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota

Abstract

Benign pulmonary lymphoid disorders include a variety of rare lymphoid abnormalities characterized by a polyclonal lymphoid infiltrate with differing histopathologic patterns and clinicoradiologic features that may overlap. Histological examination is essential to reach a correct diagnosis and to exclude alternative causes, although this task can at times prove difficult. Further studies and clinical trials are needed to provide additional insights on pathogenesis and to guide the therapeutic management of these disorders. The purpose of this article is to review the histopathological, epidemiological, and clinicoradiologic features of several benign pulmonary lymphoid disorders, including lymphoid interstitial pneumonia, follicular bronchiolitis, nodular lymphoid hyperplasia (pulmonary pseudolymphoma), inflammatory pseudotumor, immunoglobulin G4-related disease, Castleman disease, posttransplantation lymphoproliferative disease, and drug-induced lymphoid disorders.

Keywords

lymphoid interstitial pneumonia - pulmonary lymphoid disorders - pseudolymphoma - Castleman disease

Full Text

References

References
1 Lachenal F, Berger F, Ghesquières H , et al. Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients. Medicine (Baltimore) 2007; 86 (5) 282-292
2 Katzenstein A-LA, Doxtader E, Narendra S. Lymphomatoid granulomatosis: insights gained over 4 decades. Am J Surg Pathol 2010; 34 (12) e35-e48
3 Tian X, Yi ES, Ryu JH. Lymphocytic interstitial pneumonia and other benign lymphoid disorders. Semin Respir Crit Care Med 2012; 33 (5) 450-461
4 Koss MN. Pulmonary lymphoid disorders. Semin Diagn Pathol 1995; 12 (2) 158-171
5 Travis WD, Galvin JR. Non-neoplastic pulmonary lymphoid lesions. Thorax 2001; 56 (12) 964-971
6 Yi E, Aubry M-C. Pulmonary pseudoneoplasms. Arch Pathol Lab Med 2010; 134 (3) 417-426
7 Poletti V, Ravaglia C, Tomassetti S , et al. Lymphoproliferative lung disorders: clinicopathological aspects. Eur Respir Rev 2013; 22 (130) 427-436
8 Carrington B, Liebow AA. Lymphocytic interstitial pneumonia [ Abstract]. Am J Pathol 1966; 48: 36
9 Liebow AA. The interstitial pneumonias. In: Simon M, Potchen EJ, Lemay M, , eds. Frontiers in Pulmonary Radiology. 1st ed. New York: Grune & Stratton; 1969: 101-141
10 Swigris JJ, Berry GJ, Raffin TA, Kuschner WG. Lymphoid interstitial pneumonia: a narrative review. Chest 2002; 122 (6) 2150-2164
11 Guinee Jr DG. Update on nonneoplastic pulmonary lymphoproliferative disorders and related entities. Arch Pathol Lab Med 2010; 134 (5) 691-701
12 Nicholson AG, Wotherspoon AC, Diss TC , et al. Reactive pulmonary lymphoid disorders. Histopathology 1995; 26 (5) 405-412
13 Katzenstein AL. Primary Lymphoid Lung Lesions. 4th ed. Philadelphia, PA: Saunders Elsevier; 2006: 237-257
14 Tashiro K, Ohshima K, Suzumiya J , et al. Clonality of primary pulmonary lymphoproliferative disorders; using in situ hybridization and polymerase chain reaction for immunoglobulin. Leuk Lymphoma 1999; 36 (1-2) 157-167
15 Bégueret H, Vergier B, Parrens M , et al. Primary lung small B-cell lymphoma versus lymphoid hyperplasia: evaluation of diagnostic criteria in 26 cases. Am J Surg Pathol 2002; 26 (1) 76-81
16 Liebow AA, Carrington CB. Diffuse pulmonary lymphoreticular infiltrations associated with dysproteinemia. Med Clin North Am 1973; 57 (3) 809-843
17 Baqir M, Kluka EM, Aubry M-C , et al. Amyloid-associated cystic lung disease in primary Sjögren's syndrome. Respir Med 2013; 107 (4) 616-621
18 Nicholson AG. Lymphocytic interstitial pneumonia and other lymphoproliferative disorders in the lung. Semin Respir Crit Care Med 2001; 22 (4) 409-422
19 Kurosu K, Yumoto N, Rom WN , et al. Oligoclonal T cell expansions in pulmonary lymphoproliferative disorders: demonstration of the frequent occurrence of oligoclonal T cells in human immunodeficiency virus-related lymphoid interstitial pneumonia. Am J Respir Crit Care Med 2002; 165 (2) 254-259
20 Strimlan CV, Rosenow III EC, Weiland LH, Brown LR. Lymphocytic interstitial pneumonitis. Review of 13 cases. Ann Intern Med 1978; 88 (5) 616-621
21 Houghton KM, Cabral DA, Petty RE, Tucker LB. Primary Sjögren's syndrome in dizygotic adolescent twins: one case with lymphocytic interstitial pneumonia. J Rheumatol 2005; 32 (8) 1603-1606
22 Dalvi V, Gonzalez EB, Lovett L. Lymphocytic interstitial pneumonitis (LIP) in Sjögren's syndrome: a case report and a review of the literature. Clin Rheumatol 2007; 26 (8) 1339-1343
23 Yood RA, Steigman DM, Gill LR. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus. Lupus 1995; 4 (2) 161-163
24 Filipek MS, Thompson ME, Wang PL, Gosselin MV , L Primack S. Lymphocytic interstitial pneumonitis in a patient with systemic lupus erythematosus: radiographic and high-resolution CT findings. J Thorac Imaging 2004; 19 (3) 200-203
25 Uziel Y, Hen B, Cordoba M, Wolach B. Lymphocytic interstitial pneumonitis preceding polyarticular juvenile rheumatoid arthritis. Clin Exp Rheumatol 1998; 16 (5) 617-619
26 Koss MN, Hochholzer L, Langloss JM, Wehunt WD, Lazarus AA. Lymphoid interstitial pneumonia: clinicopathological and immunopathological findings in 18 cases. Pathology 1987; 19 (2) 178-185
27 Doshi AV, Desai D, Bhaduri A, Udwadia ZF. Lymphocytic interstitial pneumonitis associated with autoimmune hepatitis. Indian J Gastroenterol 2001; 20 (2) 76-77
28 Barberà JA, Hayashi S, Hegele RG, Hogg JC. Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis 1992; 145 (4, Pt 1) 940-946
29 Wheat WH, Cool CD, Morimoto Y , et al. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J Exp Med 2005; 202 (4) 479-484
30 Setoguchi Y, Takahashi S, Nukiwa T, Kira S. Detection of human T-cell lymphotropic virus type I-related antibodies in patients with lymphocytic interstitial pneumonia. Am Rev Respir Dis 1991; 144 (6) 1361-1365
31 Teirstein AS, Rosen MJ. Lymphocytic interstitial pneumonia. Clin Chest Med 1988; 9 (3) 467-471
32 Arish N, Eldor R, Fellig Y , et al. Lymphocytic interstitial pneumonia associated with common variable immunodeficiency resolved with intravenous immunoglobulins. Thorax 2006; 61 (12) 1096-1097
33 Oldham SA, Castillo M, Jacobson FL, Mones JM, Saldana MJ. HIV-associated lymphocytic interstitial pneumonia: radiologic manifestations and pathologic correlation. Radiology 1989; 170 (1, Pt 1) 83-87
34 Morris JC, Rosen MJ, Marchevsky A, Teirstein AS. Lymphocytic interstitial pneumonia in patients at risk for the acquired immune deficiency syndrome. Chest 1987; 91 (1) 63-67
35 Amorosa JK, Miller RW, Laraya-Cuasay L , et al. Bronchiectasis in children with lymphocytic interstitial pneumonia and acquired immune deficiency syndrome. Plain film and CT observations. Pediatr Radiol 1992; 22 (8) 603-606 , discussion 606–607
36 Grieco MH, Chinoy-Acharya P. Lymphocytic interstitial pneumonia associated with the acquired immune deficiency syndrome. Am Rev Respir Dis 1985; 131 (6) 952-955
37 Cha SI, Fessler MB, Cool CD, Schwarz MI, Brown KK. Lymphoid interstitial pneumonia: clinical features, associations and prognosis. Eur Respir J 2006; 28 (2) 364-369
38 Herbert A, Walters MT, Cawley MI, Godfrey RC. Lymphocytic interstitial pneumonia identified as lymphoma of mucosa associated lymphoid tissue. J Pathol 1985; 146 (2) 129-138
39 Schuurman HJ, Gooszen HC, Tan IW, Kluin PM, Wagenaar SS, van Unnik JA. Low-grade lymphoma of immature T-cell phenotype in a case of lymphocytic interstitial pneumonia and Sjögren's syndrome. Histopathology 1987; 11 (11) 1193-1204
40 Travis WD, Costabel U, Hansell DM , et al; ATS/ERS Committee on Idiopathic Interstitial Pneumonias. An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2013; 188 (6) 733-748
41 Ryu JH. Classification and approach to bronchiolar diseases. Curr Opin Pulm Med 2006; 12 (2) 145-151
42 Ryu JH, Myers JL, Swensen SJ. Bronchiolar disorders. Am J Respir Crit Care Med 2003; 168 (11) 1277-1292
43 Aerni MR, Vassallo R, Myers JL, Lindell RM, Ryu JH. Follicular bronchiolitis in surgical lung biopsies: clinical implications in 12 patients. Respir Med 2008; 102 (2) 307-312
44 Howling SJ, Hansell DM, Wells AU, Nicholson AG, Flint JD, Müller NL. Follicular bronchiolitis: thin-section CT and histologic findings. Radiology 1999; 212 (3) 637-642
45 Fortoul TI, Cano-Valle F, Oliva E, Barrios R. Follicular bronchiolitis in association with connective tissue diseases. Lung 1985; 163 (5) 305-314
46 Deheinzelin D, Capelozzi VL, Kairalla RA, Barbas Filho JV, Saldiva PH, de Carvalho CR. Interstitial lung disease in primary Sjögren's syndrome. Clinical-pathological evaluation and response to treatment. Am J Respir Crit Care Med 1996; 154 (3, Pt 1) 794-799
47 Hayakawa H, Sato A, Imokawa S, Toyoshima M, Chida K, Iwata M. Bronchiolar disease in rheumatoid arthritis. Am J Respir Crit Care Med 1996; 154 (5) 1531-1536
48 Exley CM, Suvarna SK, Matthews S. Follicular bronchiolitis as a presentation of HIV. Clin Radiol 2006; 61 (8) 710-713
49 Camarasa Escrig A, Amat Humaran B, Sapia S, León Ramírez JM. Follicular bronchiolitis associated with common variable immunodeficiency. Arch Bronconeumol 2013; 49 (4) 166-168
50 Saltzstein SL. Pulmonary malignant lymphomas and pseudolymphomas: classification, therapy, and prognosis. Cancer 1963; 16: 928-955
51 Abbondanzo SL, Rush W, Bijwaard KE, Koss MN. Nodular lymphoid hyperplasia of the lung: a clinicopathologic study of 14 cases. Am J Surg Pathol 2000; 24 (4) 587-597
52 Sakurai H, Hada M, Oyama T. Nodular lymphoid hyperplasia of the lung: a very rare disease entity. Ann Thorac Surg 2007; 83 (6) 2197-2199
53 Song MK, Seol YM, Park YE , et al. Pulmonary nodular lymphoid hyperplasia associated with Sjögren's syndrome. Korean J Intern Med 2007; 22 (3) 192-196
54 Dehner LP. Inflammatory myofibroblastic tumor: the continued definition of one type of so-called inflammatory pseudotumor. Am J Surg Pathol 2004; 28 (12) 1652-1654
55 Coffin CM, Dehner LP, Meis-Kindblom JM. Inflammatory myofibroblastic tumor, inflammatory fibrosarcoma, and related lesions: an historical review with differential diagnostic considerations. Semin Diagn Pathol 1998; 15 (2) 102-110
56 Coffin CM, Hornick JL, Fletcher CD. Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007; 31 (4) 509-520
57 Castleman B, Iverson L, Menendez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956; 9 (4) 822-830
58 Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 1998; 128 (8) 657-662
59 Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 2005; 129 (1) 3-17
60 Dupin N, Diss TL, Kellam P , et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 2000; 95 (4) 1406-1412
61 Cronin DMP, Warnke RA. Castleman disease: an update on classification and the spectrum of associated lesions. Adv Anat Pathol 2009; 16 (4) 236-246
62 Du MQ, Liu H, Diss TC , et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 2001; 97 (7) 2130-2136
63 Hillier JC, Shaw P, Miller RF , et al. Imaging features of multicentric Castleman's disease in HIV infection. Clin Radiol 2004; 59 (7) 596-601
64 Borie R, Cadranel J, Guihot A, Marcelin AG, Galicier L, Couderc LJ. Pulmonary manifestations of human herpesvirus-8 during HIV infection. Eur Respir J 2013; 42 (4) 1105-1118
65 Menter T, Schlageter M, Bastian L, Haberthür R, Rätz Bravo AE, Tzankov A. Development of an Epstein-Barr virus-associated lymphoproliferative disorder in a patient treated with azacitidine for chronic myelomonocytic leukaemia. Hematol Oncol 2014; 32 (1) 47-51
66 Bonekamp D, Horton KM, Hruban RH, Fishman EK. Castleman disease: the great mimic. Radiographics 2011; 31 (6) 1793-1807
67 Yi ES, Sekiguchi H, Peikert T, Ryu JH, Colby TV. Pathologic manifestations of Immunoglobulin(Ig)G4-related lung disease. Semin Diagn Pathol 2012; 29 (4) 219-225
68 Khosroshahi A, Wallace ZS, Crowe JL , et al; Second International Symposium on IgG4-Related Disease. International consensus guidance statement on the management and treatment of IgG4-related disease. Arthritis Rheum (Munch) 2015; 67 (7) 1688-1699
69 Zen Y, Nakanuma Y. IgG4-related disease: a cross-sectional study of 114 cases. Am J Surg Pathol 2010; 34 (12) 1812-1819
70 Kamisawa T, Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008; 14 (25) 3948-3955
71 Hamano H, Kawa S, Horiuchi A , et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001; 344 (10) 732-738
72 Ryu JH, Sekiguchi H, Yi ES. Pulmonary manifestations of immunoglobulin G4-related sclerosing disease. Eur Respir J 2012; 39 (1) 180-186
73 Sah RP, Chari ST. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol 2011; 23 (1) 108-113
74 Zen Y, Inoue D, Kitao A , et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2009; 33 (12) 1886-1893
75 Shrestha B, Sekiguchi H, Colby TV , et al. Distinctive pulmonary histopathology with increased IgG4-positive plasma cells in patients with autoimmune pancreatitis: report of 6 and 12 cases with similar histopathology. Am J Surg Pathol 2009; 33 (10) 1450-1462
76 Ryu JH, Horie R, Sekiguchi H, Peikert T, Yi ES. Spectrum of disorders associated with elevated serum IgG4 levels encountered in clinical practice. Int J Rheumatol 2012; 2012: 232960
77 Sekiguchi H, Horie R, Aksamit TR, Yi ES, Ryu JH. Immunoglobulin G4-related disease mimicking asthma. Can Respir J 2013; 20 (2) 87-89
78 Matsui S, Hebisawa A, Sakai F , et al. Immunoglobulin G4-related lung disease: clinicoradiological and pathological features. Respirology 2013; 18 (3) 480-487
79 Peikert T, Shrestha B, Aubry MC , et al. Histopathologic overlap between fibrosing mediastinitis and IgG4-related disease. Int J Rheumatol 2012; 2012: 207056
80 Ryu JH, Hu X, Yi ES. IgG4-related pleural disease. Curr Pulmonol Rep 2015; 4 (1) 22-27
81 Bhagat P, Bal A, Das A, Singh N, Singh H. Pulmonary inflammatory myofibroblastic tumor and IgG4-related inflammatory pseudotumor: a diagnostic dilemma. Virchows Arch 2013; 463 (6) 743-747
82 Zen Y, Kitagawa S, Minato H , et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 2005; 36 (7) 710-717
83 Takato H, Yasui M, Ichikawa Y , et al. Nonspecific interstitial pneumonia with abundant IgG4-positive cells infiltration, which was thought as pulmonary involvement of IgG4-related autoimmune disease. Intern Med 2008; 47 (4) 291-294
84 Duvic C, Desrame J, Lévêque C, Nedelec G. Retroperitoneal fibrosis, sclerosing pancreatitis and bronchiolitis obliterans with organizing pneumonia. Nephrol Dial Transplant 2004; 19 (9) 2397-2399
85 Rizzi R, Curci P, Delia M , et al. Spontaneous remission of “methotrexate-associated lymphoproliferative disorders” after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol 2009; 26 (1) 1-9
86 Hoshida Y, Xu JX, Fujita S , et al. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol 2007; 34 (2) 322-331
87 Van Haarlem SW, Verpalen MC, Van Gorp JM, Hoekstra JB, Van Den Bosch JM. An Epstein-Barr virus-associated pulmonary lymphoproliferative disorder as complication of immunosuppression. Neth J Med 2000; 57 (4) 165-168
88 Salloum E, Cooper DL, Howe G , et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996; 14 (6) 1943-1949
89 Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol 1991; 18 (11) 1741-1743
90 Ochi N, Yamane H, Yamagishi T, Monobe Y, Takigawa N. Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis. J Clin Oncol 2013; 31 (20) e348-e350
91 Abe H, Sato Y. [Case report; a case suspected that methotrexate-associated lymphoproliferative disorders was developed in the course of therapy of rheumatoid arthritis]. Nippon Naika Gakkai Zasshi 2011; 100 (11) 3339-3342
92 Ebeo CT, Girish MR, Byrd RP, Roy TM, Mehta JB. Methotrexate-induced pulmonary lymphoma. Chest 2003; 123 (6) 2150-2153
93 Connors W, Griffiths C, Patel J, Belletrutti PJ. Lymphomatoid granulomatosis associated with azathioprine therapy in Crohn disease. BMC Gastroenterol 2014; 14: 127
94 Barakat A, Grover K, Peshin R. Rituximab for pulmonary lymphomatoid granulomatosis which developed as a complication of methotrexate and azathioprine therapy for rheumatoid arthritis. Springerplus 2014; 3: 751
95 Ferraccioli GF, Casatta L, Bartoli E , et al. Epstein-Barr virus-associated Hodgkin's lymphoma in a rheumatoid arthritis patient treated with methotrexate and cyclosporin A. Arthritis Rheum 1995; 38 (6) 867-868
96 Ghobrial IM, Otteman LA, White WL. An EBV-positive lymphoproliferative disorder after therapy with alemtuzumab. N Engl J Med 2003; 349 (26) 2570-2572 , discussion 2570–2572
97 Nalesnik MA, Jaffe R, Starzl TE , et al. The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol 1988; 133 (1) 173-192
98 Thonhofer R, Gaugg M, Kriessmayr M, Neumann HJ, Erlacher L. Spontaneous remission of marginal zone B cell lymphoma in a patient with seropositive rheumatoid arthritis after discontinuation of infliximab-methotrexate treatment. Ann Rheum Dis 2005; 64 (7) 1098-1099
99 Dierickx D, Tousseyn T, De Wolf-Peeters C, Pirenne J, Verhoef G. Management of posttransplant lymphoproliferative disorders following solid organ transplant: an update. Leuk Lymphoma 2011; 52 (6) 950-961
100 Parker A, Bowles K, Bradley JA , et al; Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society. Diagnosis of post-transplant lymphoproliferative disorder in solid organ transplant recipients - BCSH and BTS Guidelines. Br J Haematol 2010; 149 (5) 675-692
101 Bakker NA, van Imhoff GW, Verschuuren EA , et al. Early onset post-transplant lymphoproliferative disease is associated with allograft localization. Clin Transplant 2005; 19 (3) 327-334
102 Yamakawa N, Fujimoto M, Kawabata D , et al. A clinical, pathological, and genetic characterization of methotrexate-associated lymphoproliferative disorders. J Rheumatol 2014; 41 (2) 293-299
103 Johkoh T, Müller NL, Pickford HA , et al. Lymphocytic interstitial pneumonia: thin-section CT findings in 22 patients. Radiology 1999; 212 (2) 567-572
104 Yousem SA, Colby TV, Carrington CB. Follicular bronchitis/bronchiolitis. Hum Pathol 1985; 16 (7) 700-706
105 Souid AK, Ziemba MC, Dubansky AS , et al. Inflammatory myofibroblastic tumor in children. Cancer 1993; 72 (6) 2042-2048
106 Kim JH, Cho JH, Park MS , et al. Pulmonary inflammatory pseudotumor—a report of 28 cases. Korean J Intern Med 2002; 17 (4) 252-258
107 Cerfolio RJ, Allen MS, Nascimento AG , et al. Inflammatory pseudotumors of the lung. Ann Thorac Surg 1999; 67 (4) 933-936
108 Hamano H, Arakura N, Muraki T, Ozaki Y, Kiyosawa K, Kawa S. Prevalence and distribution of extrapancreatic lesions complicating autoimmune pancreatitis. J Gastroenterol 2006; 41 (12) 1197-1205
109 Hamano H, Kawa S, Ochi Y , et al. Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis. Lancet 2002; 359 (9315) 1403-1404
110 Honda O, Johkoh T, Ichikado K , et al. Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT. AJR Am J Roentgenol 1999; 173 (1) 71-74
111 Sumikawa H, Johkoh T, Ichikado K , et al. Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients. Radiology 2006; 241 (1) 258-266
112 Ichikawa Y, Kinoshita M, Koga T, Oizumi K, Fujimoto K, Hayabuchi N. Lung cyst formation in lymphocytic interstitial pneumonia: CT features. J Comput Assist Tomogr 1994; 18 (5) 745-748
113 Suga K, Yasuhiko K, Hiyama A, Hori K, Tanaka N, Ueda K. F-18 FDG PET/CT findings in a case of multifocal nodular lymphoid hyperplasia of the lung. Clin Nucl Med 2009; 34 (6) 374-376
114 Miyoshi S, Hamada H, Katayama H , et al. A case of pulmonary nodular lymphoid hyperplasia with a resected cavity, followed by spontaneous regression of the remaining lesions. Intern Med 2010; 49 (15) 1617-1621
115 Karube Y, Chida M, Honma K, Araki O, Kobayashi S, Miyoshi S. Nodular lymphoid hyperplasia: rare case of lymphoproliferative disease in the lung. Gen Thorac Cardiovasc Surg 2009; 57 (6) 324-327
116 Narla LD, Newman B, Spottswood SS, Narla S, Kolli R. Inflammatory pseudotumor. Radiographics 2003; 23 (3) 719-729
117 Kim YH, Lee DK, Cha HG, Kim CW, Kang YC, Kang YS. Preparation and characterization of the antibacterial Cu nanoparticle formed on the surface of SiO2 nanoparticles. J Phys Chem B 2006; 110 (49) 24923-24928
118 Kato S, Kondo K, Teramoto T , et al. A case report of inflammatory pseudotumor of the lung: rapid recurrence appearing as multiple lung nodules. Ann Thorac Cardiovasc Surg 2002; 8 (4) 224-227
119 Calderazzo M, Gallelli A, Barbieri V , et al. Inflammatory pseudotumour of the lung presenting as an airway obstructive syndrome. Respir Med 1997; 91 (6) 381-384
120 Huellner MW, Schwizer B, Burger I , et al. Inflammatory pseudotumor of the lung with high FDG uptake. Clin Nucl Med 2010; 35 (9) 722-723
121 Dong A, Wang Y, Dong H , et al. Inflammatory myofibroblastic tumor: FDG PET/CT findings with pathologic correlation. Clin Nucl Med 2014; 39 (2) 113-121
122 Barrie JR, English JC, Müller N. Castleman's disease of the lung: radiographic, high-resolution CT, and pathologic findings. AJR Am J Roentgenol 1996; 166 (5) 1055-1056
123 McAdams HP, Rosado-de-Christenson M, Fishback NF, Templeton PA. Castleman disease of the thorax: radiologic features with clinical and histopathologic correlation. Radiology 1998; 209 (1) 221-228
124 Barker R, Kazmi F, Stebbing J , et al. FDG-PET/CT imaging in the management of HIV-associated multicentric Castleman's disease. Eur J Nucl Med Mol Imaging 2009; 36 (4) 648-652
125 Inoue D, Zen Y, Abo H , et al. Immunoglobulin G4-related lung disease: CT findings with pathologic correlations. Radiology 2009; 251 (1) 260-270
126 Matsui S, Taki H, Shinoda K , et al. Respiratory involvement in IgG4-related Mikulicz's disease. Mod Rheumatol 2012; 22 (1) 31-39
127 Ebbo M, Grados A, Guedj E , et al. Usefulness of 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res (Hoboken) 2014; 66 (1) 86-96
128 Nakatani K, Nakamoto Y, Togashi K. Utility of FDG PET/CT in IgG4-related systemic disease. Clin Radiol 2012; 67 (4) 297-305
129 Borhani AA, Hosseinzadeh K, Almusa O, Furlan A, Nalesnik M. Imaging of posttransplantation lymphoproliferative disorder after solid organ transplantation. Radiographics 2009; 29 (4) 981-1000 , discussion 1000–1002
130 Scarsbrook AF, Warakaulle DR, Dattani M, Traill Z. Post-transplantation lymphoproliferative disorder: the spectrum of imaging appearances. Clin Radiol 2005; 60 (1) 47-55
131 Kuramoto R, Hirata K, Takei T , et al. FDG PET/CT in a patient with spontaneous remission of methotrexate-associated lymphoproliferative disorders after interruption of methotrexate. Clin Nucl Med 2011; 36 (7) 582-583
132 Meyer KC, Raghu G, Baughman RP , et al; American Thoracic Society Committee on BAL in Interstitial Lung Disease. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2012; 185 (9) 1004-1014
133 Chang SY, Keogh K, Lewis JE, Ryu JH, Yi ES. Increased IgG4-positive plasma cells in granulomatosis with polyangiitis: adiagnostic pitfall of IgG4-related disease. Int J Rheumatol 2012; 2012: 121702
134 Wallace ZS, Stone JH. An update on IgG4-related disease. Curr Opin Rheumatol 2015; 27 (1) 83-90
135 Ripamonti D, Rizzi M, Maggiolo F, Arici C, Suter F. Resolution of lymphocytic interstitial pneumonia in a human immunodeficiency virus-infected adult following the start of highly active antiretroviral therapy. Scand J Infect Dis 2003; 35 (5) 348-351
136 Dufour V, Wislez M, Bergot E, Mayaud C, Cadranel J. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy. Clin Infect Dis 2003; 36 (10) e127-e130
137 Popa V. Lymphocytic interstitial pneumonia of common variable immunodeficiency. Ann Allergy 1988; 60 (3) 203-206
138 Banerjee D, Ahmad D. Malignant lymphoma complicating lymphocytic interstitial pneumonia: a monoclonal B-cell neoplasm arising in a polyclonal lymphoproliferative disorder. Hum Pathol 1982; 13 (8) 780-782
139 Kradin RL, Young RH, Kradin LA, Mark EJ. Immunoblastic lymphoma arising in chronic lymphoid hyperplasia of the pulmonary interstitium. Cancer 1982; 50 (7) 1339-1343
140 Hamlyn E, Ibrahim MA, Post FA. Resolution of HIV-associated adult lymphocytic interstitial pneumonitis in pregnancy. AIDS 2008; 22 (10) 1244-1245
141 Sandanayake NS, Church NI, Chapman MH , et al. Presentation and management of post-treatment relapse in autoimmune pancreatitis/immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol 2009; 7 (10) 1089-1096
142 Kamisawa T, Okazaki K, Kawa S , et al; Working Committee of the Japan Pancreas Society and the Research Committee for Intractable Pancreatic Disease supported by the Ministry of Health, Labour and Welfare of Japan. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol 2014; 49 (6) 961-970
143 Kobayashi H, Shimokawaji T, Kanoh S, Motoyoshi K, Aida S. IgG4-positive pulmonary disease. J Thorac Imaging 2007; 22 (4) 360-362
144 Khan ML, Colby TV, Viggiano RW, Fonseca R. Treatment with bortezomib of a patient having hyper IgG4 disease. Clin Lymphoma Myeloma Leuk 2010; 10 (3) 217-219
145 Carruthers MN, Topazian MD, Khosroshahi A , et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis 2015; 74 (6) 1171-1177
146 Alexiou C, Obuszko Z, Beggs D, Morgan WE. Inflammatory pseudotumors of the lung. Ann Thorac Surg 1998; 66 (3) 948-950
147 Estephan FF, Elghetany MT, Berry M, Jones Jr DV. Complete remission with anti-CD20 therapy for unicentric, non-HIV-associated, hyaline-vascular type, Castleman's disease. Cancer Invest 2005; 23 (2) 191
148 van Rhee F, Wong RS, Munshi N , et al. Siltuximab for multicentric Castleman's disease: a randomised, double-blind, placebo-controlled trial. Lancet Oncol 2014; 15 (9) 966-974
149 Nishimoto N, Kanakura T, Aozasa K , et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 2005; 106 (8) 2627-2632
150 Soumerai JD, Sohani AR, Abramson JS. Diagnosis and management of Castleman disease. Cancer Control 2014; 21 (4) 255-278
151 Parker A, Bowles K, Bradley JA , et al; Haemato-oncology Task Force of the British Committee for Standards in Haematology and British Transplantation Society. Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines. Br J Haematol 2010; 149 (5) 693-705
152 van Esser JW, Niesters HG, van der Holt B , et al. Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation. Blood 2002; 99 (12) 4364-4369
153 Choquet S, Leblond V, Herbrecht R , et al. Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study. Blood 2006; 107 (8) 3053-3057
154 Trappe R, Oertel S, Leblond V , et al; German PTLD Study Group; European PTLD Network. Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial. Lancet Oncol 2012; 13 (2) 196-206